Sprint Financial Statements From 2010 to 2024
| SPRINT Stock | SEK 1.82 0.02 1.09% |
Check Sprint Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sprint Bioscience's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sprint financial statements analysis is a perfect complement when working with Sprint Bioscience Valuation or Volatility modules.
Sprint |
Sprint Bioscience AB Company Return On Equity Analysis
Sprint Bioscience's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sprint Bioscience Return On Equity | -1.09 |
Most of Sprint Bioscience's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sprint Bioscience AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sprint Bioscience AB has a Return On Equity of -1.0926. This is 95.44% lower than that of the Healthcare sector and notably lower than that of the Drug Manufacturers - Specialty & Generic industry. The return on equity for all Sweden stocks is notably higher than that of the company.
Sprint Bioscience Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sprint Bioscience's current stock value. Our valuation model uses many indicators to compare Sprint Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sprint Bioscience competition to find correlations between indicators driving Sprint Bioscience's intrinsic value. More Info.Sprint Bioscience AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sprint Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sprint Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Sprint Bioscience Financial Statements
Sprint Bioscience stakeholders use historical fundamental indicators, such as Sprint Bioscience's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sprint Bioscience investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sprint Bioscience's assets and liabilities are reflected in the revenues and expenses on Sprint Bioscience's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sprint Bioscience AB. Please read more on our technical analysis and fundamental analysis pages.
Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism. Sprint Bioscience AB was founded in 2009 and is based in Huddinge, Sweden. Sprint Bioscience operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Sprint Stock
Sprint Bioscience financial ratios help investors to determine whether Sprint Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sprint with respect to the benefits of owning Sprint Bioscience security.